Annabel addressed the following topics:
- Plausibility and the need for data in the application as filed
- The prior art effect of clinical trial protocols and other data free disclosures
- Possibly diverging approaches from different EPO Boards of Appeal
- Selected examples from the national courts
If you would like to view the recording for this webinar, please contact our marketing department.